Fig. 2From: Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapyBrain MRI obtained after treatment with steroids in setting of continued neurological complaints. T1-weighted contrast-enhanced axial images at a the level of the internal capsule and b the level of the corona radiata. Note the increased leptomeningeal enhancement (arrows) and new patchy areas of adjacent parenchymal enhancement (arrowheads)Back to article page